
The State Struggle: Paying for Excessively Priced Drugs
High-priced treatments continue to crush state budgets. With more drugs carrying 6-figure price tags, a problematic situation is playing out across the country.
High-priced treatments continue to crush state budgets. California, for example, has set aside $300 million to pay for new hepatitis C drugs. But unfortunately, that cost is just the tip of the iceberg, according to an article from The Fresno Bee.
With more
Read more at AHIP Coverage:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.